Helmerich & Payne (HP) has disclosed a new risk, in the Regulation category.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The analyst notes that Helmerich & Payne reports no material changes to previously disclosed risk factors, signaling continuity in its risk profile since the 2025 Form 10-K. This stability may reassure investors, but it also implies that existing exposures remain fully in force and must still be monitored in the current Q2 FY26 environment.
The average HP stock price target is $39.60, implying 4.82% upside potential.
To learn more about Helmerich & Payne’s risk factors, click here.